Novo Seeds, the early stage investment and company creation team of Novo Holdings, today announced that it is leading a €7m seed investment into Bactolife, a Danish start-up developing novel biological solutions to reduce the risk of gastrointestinal...
A Danish project, called Ablacto+, will determine the efficacy and safety of using a nanobody-based product in piglets to prevent outbreaks of E. coli induced post-weaning diarrhea.